129 related articles for article (PubMed ID: 24583048)
1. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes.
Li Y; Shen D; Tang X; Li X; Wo D; Yan H; Song R; Feng J; Li P; Zhang J; Li J
Toxicol Lett; 2014 May; 226(3):257-63. PubMed ID: 24583048
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
4. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
[TBL] [Abstract][Full Text] [Related]
5. Chlorogenic acid attenuates cardiac hypertrophy via up-regulating Sphingosine-1-phosphate receptor1 to inhibit endoplasmic reticulum stress.
Ping P; Yang T; Ning C; Zhao Q; Zhao Y; Yang T; Gao Z; Fu S
ESC Heart Fail; 2024 Jun; 11(3):1580-1593. PubMed ID: 38369950
[TBL] [Abstract][Full Text] [Related]
6. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
[TBL] [Abstract][Full Text] [Related]
7. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy.
Chatterjee A; Mir SA; Dutta D; Mitra A; Pathak K; Sarkar S
J Cell Physiol; 2011 Oct; 226(10):2543-54. PubMed ID: 21792911
[TBL] [Abstract][Full Text] [Related]
11. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
[TBL] [Abstract][Full Text] [Related]
12. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.
Liu C; Cao F; Tang QZ; Yan L; Dong YG; Zhu LH; Wang L; Bian ZY; Li H
J Nutr Biochem; 2010 Dec; 21(12):1238-50. PubMed ID: 20185286
[TBL] [Abstract][Full Text] [Related]
13. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Yu L; She T; Li M; Shi C; Han L; Cheng M
Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
[TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
[TBL] [Abstract][Full Text] [Related]
15. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
16. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
[TBL] [Abstract][Full Text] [Related]
17. Protective Action of Diazoxide on Isoproterenol-Induced Hypertrophy Is Mediated by Reduction in MicroRNA-132 Expression.
Narasimhan G; Carrillo ED; Hernández A; García MC; Sánchez JA
J Cardiovasc Pharmacol; 2018 Nov; 72(5):222-230. PubMed ID: 30403388
[TBL] [Abstract][Full Text] [Related]
18. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
19. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway.
Shi H; Dong L; Jiang J; Zhao J; Zhao G; Dang X; Lu X; Jia M
Toxicology; 2013 Jan; 303():107-14. PubMed ID: 23146752
[TBL] [Abstract][Full Text] [Related]
20. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
